Does Serotonin Augmentation Have Any Effect on Cognition and Activities of Daily Living in Alzheimer's Dementia?: A Double-Blind, Placebo-Controlled Clinical Trial
暂无分享,去创建一个
Afshin Borhani Haghighi | A. B. Haghighi | H. Haghshenas | A. Mowla | Arash Mowla | Masoud Mosavinasab | Hasan Haghshenas | M. Mosavinasab
[1] M. Hamilton,et al. Development of a rating scale for primary depressive illness. , 1967, The British journal of social and clinical psychology.
[2] D. Price,et al. Age-related changes in multiple neurotransmitter systems in the monkey brain , 1989, Neurobiology of Aging.
[3] P. Delgado,et al. Alzheimer disease, serotonin systems, and tryptophan depletion. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[4] M. D. O'Brien,et al. Cerebral blood flow in dementia , 1986, Neurology.
[5] H. Manev,et al. Fluoxetine increases the content of neurotrophic protein S100beta in the rat hippocampus. , 2001, European journal of pharmacology.
[6] B. Reisberg,et al. Brief Cognitive Rating Scale (BCRS). , 1988, Psychopharmacology bulletin.
[7] P. Cowen,et al. Low-dose tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symptoms , 2005, Biological Psychiatry.
[8] Eric J. Nestler,et al. Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus , 2000, The Journal of Neuroscience.
[9] J L Mack,et al. Assessment of Functional Ability in Alzheimer Disease: A Review and a Preliminary Report on the Cleveland Scale for Activities of Daily Living , 1992, Alzheimer disease and associated disorders.
[10] H Merskey,et al. Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease. , 1993, Archives of neurology.
[11] Eric Vermetten,et al. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment , 2004, Biological Psychiatry.
[12] M. Lawton,et al. Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.
[13] D. Kupfer,et al. Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imaging , 1998, Neuropsychopharmacology.
[14] L. Iversen,et al. Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease. , 1986, British medical bulletin.
[15] M. Esiri,et al. Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease , 2002, Neuroreport.
[16] S. DeKosky,et al. Monoamine neurons in aging and Alzheimer's disease , 2005, Journal of Neural Transmission / General Section JNT.
[17] S. Marumoto,et al. Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimer's disease. , 2003, Journal of pharmacological sciences.
[18] B. Jacobs,et al. Adult brain neurogenesis and psychiatry: a novel theory of depression , 2000, Molecular Psychiatry.
[19] David Wechsler,et al. Wechsler Memory scale. , 2005 .
[20] E. Gould,et al. Neurogenesis in the Dentate Gyrus of the Adult Tree Shrew Is Regulated by Psychosocial Stress and NMDA Receptor Activation , 1997, The Journal of Neuroscience.
[21] J L McGaugh,et al. The role of interactions between the cholinergic system and other neuromodulatory systems in learing and memory , 1991, Synapse.
[22] P. Riekkinen,et al. Interaction between 5-HT1A and nicotinic cholinergic receptors in the regulation of water maze navigation behavior , 1994, Brain Research.
[23] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[24] W J Riedel,et al. Serotonin and human cognitive performance. , 2006, Current pharmaceutical design.
[25] Rita Moretti,et al. Depression and Alzheimer's disease: Symptom or comorbidity? , 2002, American journal of Alzheimer's disease and other dementias.
[26] Steven M. Southwick,et al. Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder , 2003, Biological Psychiatry.
[27] G. Grossberg,et al. Behavioral and Psychological Symptoms of Dementia as a Risk Factor for Nursing Home Placement , 2000, International Psychogeriatrics.
[28] G. Iverson. Interpreting change on the WAIS-III/WMS-III in clinical samples. , 2001, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.
[29] P. Francis,et al. Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms , 1992, Neurochemical Research.